| Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study KA Al Sulaiman, O Aljuhani, K Eljaaly, AA Alharbi, AM Al Shabasy, ... International Journal of Infectious Diseases 105, 180-187, 2021 | 54 | 2021 |
| Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: A propensity score matched study K Al Sulaiman, O Aljuhani, KB Saleh, HA Badreldin, A Al Harthi, M Alenazi, ... Scientific reports 11 (1), 17648, 2021 | 52 | 2021 |
| Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study K Al Sulaiman, O Aljuhani, M Al Dossari, A Alshahrani, A Alharbi, ... Critical Care 25, 1-8, 2021 | 35 | 2021 |
| Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study K Al Sulaiman, O Aljuhani, AI Al Shaya, A Kharbosh, R Kensara, ... Critical Care 25, 1-8, 2021 | 35 | 2021 |
| Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study K Al Sulaiman, GB Korayem, AF Altebainawi, S Al Harbi, A Alissa, ... Critical Care 26 (1), 304, 2022 | 25 | 2022 |
| Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy GB Korayem, HA Badreldin, K Eljaaly, A Aldemerdash, LK Al-Suhaibani, ... Saudi Pharmaceutical Journal 29 (11), 1343-1347, 2021 | 22 | 2021 |
| Methocarbamol use is associated with decreased hospital length of stay in trauma patients with closed rib fractures AE Patanwala, O Aljuhani, BJ Kopp, BL Erstad The American Journal of Surgery 214 (4), 738-742, 2017 | 20 | 2017 |
| Effect of methocarbamol on acute pain after traumatic injury O Aljuhani, BJ Kopp, AE Patanwala American Journal of Therapeutics 24 (2), e202-e206, 2017 | 17 | 2017 |
| Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): a multicenter cohort study KB Saleh, A Hafiz, K Alsulaiman, O Aljuhani, S Alharbi, A Alharbi, ... American Heart Journal Plus: Cardiology Research and Practice 7, 100033, 2021 | 14 | 2021 |
| A cross-sectional study of predictors of pain control during the transition from the surgical intensive care unit to surgical ward AE Patanwala, O Aljuhani, BL Erstad Australian Critical Care 31 (3), 159-164, 2018 | 13 | 2018 |
| Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study K Al Sulaiman, HA Badreldin, GB Korayem, AA Alenazi, F Alsuwayyid, ... Thrombosis Journal 20 (1), 25, 2022 | 12 | 2022 |
| The role of inhaled corticosteroids (ICS) in critically Ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, K Al Aamer, O Al Shaya, A Al Shaya, ... Journal of Intensive Care Medicine 37 (2), 248-257, 2022 | 12 | 2022 |
| The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: therapy section W Alhazzani, M Alshahrani, F Alshamsi, O Aljuhani, K Eljaaly, S Hashim, ... Journal of Infection and Public Health 15 (1), 142-151, 2022 | 12 | 2022 |
| Clostridium difficile infection in an academic medical center in Saudi Arabia: prevalence and risk factors M Alalawi, S Aljahdali, B Alharbi, L Fagih, R Fatani, O Aljuhani Annals of Saudi Medicine 40 (4), 305-309, 2020 | 9 | 2020 |
| The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study K Al Sulaiman, O Aljuhani, HA Badreldin, GB Korayem, AA Alenazi, ... BMC infectious diseases 23 (1), 75, 2023 | 8 | 2023 |
| Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study O Aljuhani, K Al Sulaiman, A Alshabasy, K Eljaaly, AI Al Shaya, ... BMC Infectious Diseases 21, 1-8, 2021 | 8 | 2021 |
| Evaluation of low-dose aspirin use among critically Ill patients with COVID-19: A multicenter propensity score matched study AF Al Harthi, O Aljuhani, GB Korayem, AF Altebainawi, RS Alenezi, ... Journal of Intensive Care Medicine 37 (9), 1238-1249, 2022 | 7 | 2022 |
| Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study O Aljuhani, K Al Sulaiman, A Hafiz, K Eljaaly, A Alharbi, R Algarni, ... Saudi Pharmaceutical Journal 30 (4), 398-406, 2022 | 7 | 2022 |
| Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study K Al Sulaiman, O Aljuhani, KB Salah, GB Korayem, K Eljaaly, M Al Essa, ... Journal of Critical Care 66, 44-51, 2021 | 7 | 2021 |
| Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study K Al Sulaiman, O Aljuhani, GB Korayem, A Hafiz, M Alalawi, HA Badreldin, ... Thrombosis Journal 20 (1), 74, 2022 | 6 | 2022 |
Dr. Khalid Al SulaimanKing Abdulaziz Medical City在 ngha.med.sa 的电子邮件经过验证
